RUA Life Sciences (AIM:RUA), the holding company of a group of medical device businesses focused on the exploitation of the world's leading long-term implantable biostable polymer (Elast-Eon), conducted an Investor Presentation covering their interim results for the period ended 30th September 2022.
Bill Brown (Chairman) and Caroline Stretton (CEO) ran investors through the financial highlights of the first half, their heroic efforts to manage working capital and the growth in revenues of 56% compared to the same period in 2021. They also took investors through the product progress they are making in their four divisions. Management answered investor questions, and the full video has been divided into chapters for ease of viewing.
00:03 introduction
02:04 Financial highlights
06:59 Biomaterials
11:47 Contract Manufacture
16:29 Vascular
28:19 Structural Heart
38:23 Questions & Answers
26810392321 - rua-life-sciences
Return to RUA Life Sciences
